Biocept reports 2022 financial results

San diego--(business wire)--biocept, inc. (nasdaq: bioc), a leading provider of molecular diagnostic assays, products and services, reports financial results for the 12 months ended december 31, 2022 and provides a business update. “i could not be prouder of my biocept colleagues as together we have worked tirelessly to streamline operations, prioritize decisions to advance our corporate mission and carefully manage expenditures.
BIOC Ratings Summary
BIOC Quant Ranking